Il Dong Pharmaceutical Co Ltd (249420) — Financial Flexibility Index
Il Dong Pharmaceutical Co Ltd (249420) has a Financial Flexibility Index of 0.05x as of September 2025. Free cash flow of ₩17.26 Billion (operating CF ₩11.28 Billion minus capex ₩5.97 Billion) represents 0% of total liabilities (₩347.04 Billion). Check 249420 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Il Dong Pharmaceutical Co Ltd Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Il Dong Pharmaceutical Co Ltd across 9 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Il Dong Pharmaceutical Co Ltd.
Annual Financial Flexibility Index for Il Dong Pharmaceutical Co Ltd (2016–2024)
Year-by-year free cash flow to debt coverage for Il Dong Pharmaceutical Co Ltd. Explore Il Dong Pharmaceutical Co Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | ₩42.35 Billion | ₩28.29 Billion | ₩429.99 Billion | ▲ +333.5% |
| 2023 | -0.04x | ₩-18.43 Billion | ₩-36.62 Billion | ₩437.00 Billion | ▲ +53.7% |
| 2022 | -0.09x | ₩-41.67 Billion | ₩-53.54 Billion | ₩457.59 Billion | ▼ -1631.9% |
| 2021 | 0.01x | ₩3.26 Billion | ₩-11.37 Billion | ₩548.39 Billion | ▼ -93.8% |
| 2020 | 0.10x | ₩33.72 Billion | ₩19.37 Billion | ₩350.73 Billion | ▼ -35.3% |
| 2019 | 0.15x | ₩53.43 Billion | ₩41.37 Billion | ₩359.83 Billion | ▼ -47.7% |
| 2018 | 0.28x | ₩81.73 Billion | ₩66.65 Billion | ₩287.84 Billion | ▼ -12.2% |
| 2017 | 0.32x | ₩90.45 Billion | ₩73.72 Billion | ₩279.55 Billion | ▲ +51.5% |
| 2016 | 0.21x | ₩60.20 Billion | ₩45.98 Billion | ₩281.94 Billion | — |